Longwang Wang
Impact in
-
- Cancer-related molecular mechanisms research
- Urology top 10%
- Urinary Bladder and Prostate Research
Papers in ⓘ
-
- Epigenetics and DNA Methylation 3
- Ubiquitin and proteasome pathways 3
-
- Ferroptosis and cancer prognosis 7
- Renal cell carcinoma treatment 4
- Co-authors
- Gallina Kazobinka (7 shared papers)Xiaomin Han (6 shared papers)Qiufeng Pan (7 shared papers)Xiaoping Zhang (5 shared papers)Lijie Zhou (4 shared papers)Teng Hou (4 shared papers)Bin Li (2 shared papers)Zhaohui Chen (2 shared papers)
- Journals
- Laboratory Investigation (2 papers)Cellular Physiology and Biochemistry (2 papers)Molecular Carcinogenesis (1 paper)Scientific Reports (1 paper)Aging (1 paper)
- Partner nations
- China
In The Last Decade
Longwang Wang
23 papers receiving 457 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 114
- Urology 47
- Pulmonary and Respiratory Medicine 154
- Molecular Biology 263
- Oncology 85
Countries citing papers authored by Longwang Wang
This map shows the geographic impact of Longwang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longwang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longwang Wang more than expected).
Fields of papers citing papers by Longwang Wang
This network shows the impact of papers produced by Longwang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longwang Wang. The network helps show where Longwang Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Longwang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 54 | |
| 2 | 2020 | 53 | |
| 3 | 2017 | 44 | |
| 4 | 2013 | 39 | |
| 5 | 2017 | 39 | |
| 6 | 2017 | 34 | |
| 7 | 2020 | 28 | |
| 8 | 2020 | 26 | |
| 9 | 2019 | 26 | |
| 10 | 2017 | 25 | |
| 11 | 2018 | 24 | |
| 12 | 2012 | 13 | |
| 13 | 2018 | 11 | |
| 14 | 2017 | 8 | |
| 15 | 2016 | 7 | |
| 16 | 2022 | 6 | |
| 17 | 2018 | 5 | |
| 18 | 2013 | 5 | |
| 19 | 2012 | 4 | |
| 20 | SKIP expression is correlated with clinical prognosis in patients with bladder cancer. | 2014 | 4 |
About Longwang Wang
Longwang Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Urology and Rheumatology, having authored 25 papers that have together received 461 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (7 papers), Urinary Bladder and Prostate Research (6 papers), Bladder and Urothelial Cancer Treatments (5 papers), Pelvic floor disorders treatments (5 papers), Cancer-related molecular mechanisms research (4 papers), Renal cell carcinoma treatment (4 papers), Epigenetics and DNA Methylation (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Cancer Research (114 citations), Urology (47 citations), Pulmonary and Respiratory Medicine (154 citations), Molecular Biology (263 citations) and Oncology (85 citations). Longwang Wang has collaborated with scholars based in China. Frequent co-authors include Gallina Kazobinka, Xiaomin Han, Qiufeng Pan, Xiaoping Zhang, Lijie Zhou, Teng Hou, Bin Li, Teng Hou, Zhaohui Chen and Yan Ma. Their work appears in journals such as Laboratory Investigation, Cellular Physiology and Biochemistry, Molecular Carcinogenesis, Scientific Reports and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.